Skip to main content

Find Clinical Trials

Home
Conditions
Transformed Recurrent Non-Hodgkin Lymphoma

Clinical trial condition

Transformed Recurrent Non-Hodgkin Lymphoma

Explore clinical trials studying Transformed Recurrent Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

5 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Transformed Recurrent Non-Hodgkin Lymphoma trial results

Completed

Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma

NCT02652715

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Adult T-Cell Leukemia/Lymphoma, Anaplastic Large Cell Lymphoma, +76 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

NCT01719250

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +15 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Active, Not Recruiting

Memory Enriched T Cells Following Stem Cell Transplant in Treating Patients With Recurrent B-Cell Non-Hodgkin Lymphoma

NCT02051257

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma

NCT03147885

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Diffuse Large B-cell Lymphoma, +35 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Active, Not Recruiting

Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT02992522

Conditions: B-Cell, B-Cell Lymphoma, Unspecified, Burkitt Lymphoma, +30 more
Locations: Emory University Atlanta, Georgia, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details